JP2009515996A5 - - Google Patents

Download PDF

Info

Publication number
JP2009515996A5
JP2009515996A5 JP2008541386A JP2008541386A JP2009515996A5 JP 2009515996 A5 JP2009515996 A5 JP 2009515996A5 JP 2008541386 A JP2008541386 A JP 2008541386A JP 2008541386 A JP2008541386 A JP 2008541386A JP 2009515996 A5 JP2009515996 A5 JP 2009515996A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
cyano
nitro
haloalkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008541386A
Other languages
English (en)
Japanese (ja)
Other versions
JP5344923B2 (ja
JP2009515996A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/044799 external-priority patent/WO2007061909A1/en
Publication of JP2009515996A publication Critical patent/JP2009515996A/ja
Publication of JP2009515996A5 publication Critical patent/JP2009515996A5/ja
Application granted granted Critical
Publication of JP5344923B2 publication Critical patent/JP5344923B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008541386A 2005-11-18 2006-11-17 増殖性疾患の治療のためのチアゾール Expired - Fee Related JP5344923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73834005P 2005-11-18 2005-11-18
US60/738,340 2005-11-18
PCT/US2006/044799 WO2007061909A1 (en) 2005-11-18 2006-11-17 Thiazoles for the treatment of proliferative disorders

Publications (3)

Publication Number Publication Date
JP2009515996A JP2009515996A (ja) 2009-04-16
JP2009515996A5 true JP2009515996A5 (https=) 2010-01-14
JP5344923B2 JP5344923B2 (ja) 2013-11-20

Family

ID=37813575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541386A Expired - Fee Related JP5344923B2 (ja) 2005-11-18 2006-11-17 増殖性疾患の治療のためのチアゾール

Country Status (7)

Country Link
US (4) US7572821B2 (https=)
EP (1) EP1966172B1 (https=)
JP (1) JP5344923B2 (https=)
AU (1) AU2006318709B2 (https=)
CA (1) CA2628958A1 (https=)
TW (1) TW200735866A (https=)
WO (1) WO2007061909A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200735866A (en) 2005-11-18 2007-10-01 Synta Pharmaceuticals Corp Compounds for the treatment of proliferative disorders
CA2720631C (en) 2008-04-04 2012-08-28 Eli Lilly And Company 3-indazolyl-4-pyridylisothiazoles
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
EP3082853A2 (en) 2013-12-20 2016-10-26 The Broad Institute, Inc. Combination therapy with neoantigen vaccine
WO2015166860A1 (ja) * 2014-04-30 2015-11-05 日本カーバイド工業株式会社 オキシラン化合物及びそれを用いた含窒素複素環式化合物を製造する方法
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
US10993997B2 (en) 2014-12-19 2021-05-04 The Broad Institute, Inc. Methods for profiling the t cell repertoire

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840749A (en) 1989-08-25 1998-11-24 Hoechst Marion Roussel, Inc. N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues
US5840746A (en) * 1993-06-24 1998-11-24 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
ATE268176T1 (de) * 1995-07-19 2004-06-15 Merck & Co Inc Behandlungsverfahren für darmadenome
BR9914730B1 (pt) * 1998-10-23 2011-11-16 compostos 3-(fenil substituìdo)- 5-(heterociclil substituìdo)-1, 2, 4-triazol, seu processo de preparação, composição e método não terapêutico para controlar insetos ou ácaros, método de proteger uma planta de afìdios, ácaros ou insetos.
KR100567125B1 (ko) 2001-11-01 2006-03-31 주식회사 안지오랩 칼콘 또는 이의 유도체를 함유하는 매트릭스메탈로프로테아제 활성 억제용 약학 조성물
KR100484525B1 (ko) 2002-10-15 2005-04-20 씨제이 주식회사 이소티아졸 유도체, 그 제조방법 및 약제학적 조성물
US7807696B2 (en) * 2003-10-07 2010-10-05 The Feinstein Institute For Medical Research Isoxazole and isothiazole compounds useful in the treatment of inflammation
TWI262618B (en) * 2004-11-03 2006-09-21 Tatung Co A co-precipitation method for Li1+xNi1-yCoyO2-based cathode materials
TW200735866A (en) 2005-11-18 2007-10-01 Synta Pharmaceuticals Corp Compounds for the treatment of proliferative disorders
AU2007294752A1 (en) * 2006-09-14 2008-03-20 Synta Pharmaceuticals Corp. Compounds for the treatment of angiogenesis

Similar Documents

Publication Publication Date Title
JP2008530240A5 (https=)
CA2746985C (en) Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
AU2009334511C1 (en) Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US20210038636A1 (en) Potassium binding polymers for treating hypertension and hyperkalemia
CN101707888B (zh) 用7-乙基-10-羟基喜树碱的多臂聚合物缀合物治疗非霍奇金氏淋巴瘤
ES2699494T3 (es) Composiciones que comprenden polímeros reticulados de intercambio catiónico y uso en el tratamiento de la hipercalemia
CN112851928B (zh) 一种聚乙二醇偶联药物、其制备方法及用途
JP5037684B2 (ja) ドセタキセル高分子誘導体、並びにその製造方法及びその用途
HRP20191138T1 (hr) Oblici kisele soli konjugata polimer-lijeka
JP2009515996A5 (https=)
CA2597430A1 (en) Isoxazole combretastin derivatives for the treatment of disorders
JP2009504763A5 (https=)
RU2009122582A (ru) Пэг-модифицированный эксендин или аналог эксендина и его композиции и применение
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
CA2581125A1 (en) Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same
JP2015522001A5 (https=)
JP2013504576A5 (https=)
JP2010503674A5 (https=)
US20170095504A1 (en) Inhibitors of Kidney Stone Formation and Calcium Deposition
CN101199857B (zh) mPEG-PLA-喜树碱类药物的结合物
EP2491951B1 (en) Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
JP2007500158A5 (https=)
JP2008518024A5 (https=)
CN104860932A (zh) 一种吡唑啉酮类化合物及其应用
RU2017134594A (ru) Фармацевтическая композиция, включающая полипептид